Our results provide a new understanding of the role and mechanism of the LINC00470/miR‐134/MYC/ABCC1 axis in glioma, which may contribute to the development of novel therapeutic targets and improve the chemosensitivity of glioma. The gene discussed is LINC00470; the disease is central nervous system cancer.